Zhang L, Wang Z, Fang J, Yu Q, et al. Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study. Lung Cancer 2022;171:56-60.
PMID: 35917647